Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference

Century Therapeutics

PHILADELPHIA, PACentury Therapeutics, Inc. (NASDAQ: IPSC) announced that Chief Scientific Officer Chad Cowan, Ph.D., will deliver a presentation at Chardan’s 9th Annual Genetic Medicines Conference on Tuesday, October 21, 2025, at 12:20 p.m. ET in New York City.

A live webcast of the presentation will be accessible via the Investors section of Century’s website at www.centurytx.com, with a replay available for at least 30 days following the event.

Century Therapeutics is a clinical-stage biotechnology company developing induced pluripotent stem cell (iPSC)-derived therapies designed to treat autoimmune diseases and cancer. Using its proprietary Allo-Evasion™ immune evasion technology and iPSC cell foundry, the company aims to create scalable, off-the-shelf cell therapies that enhance patient access and improve treatment outcomes compared to existing autologous approaches.

READ:  TENA Launches Skin-Focused Incontinence Pads with Aloe and Vitamin E

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.